RUELLA, Marco
RUELLA, Marco
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
2025-01-01 Fiore, Danilo; Cappelli, Luca Vincenzo; Zhaoqi, Liu; Kotlov, Nikita; Sorokina, Maria; Phillip, Jude; Zumbo, Paul; Yoffe, Liron; Ghione, Paola; Wang, Anqi; Han, Xueshuai; Taylor, Abigail; Chiu, William; Fragliasso, Valentina; Tabbo, Fabrizio; Zamponi, Nahuel; Di Siervi, Nicolás; Kayembe, Clarisse; Medico, Giovanni; Patel, Ruchi P; Gaudiano, Marcello; Machiorlatti, Rodolfo; Astone, Giuseppina; Cacciapuoti, Maria Teresa; Zanetti, Giorgia; Pignataro, Claudia; Eric, Ruiz Arvin; Patel, Sanjay; Zammarchi, Francesca; Zanettini, Claudio; Queiroz, Lucio; Nikitina, Anastasia; Kudryashova, Olga; Karelin, Anton; Nikitin, Daniil; Tychinin, Dmitry; Postovalova, Ekaterina; Bagaev, Alexander; Svekolkin, Viktor; Belova, Ekaterina; Tikhonova, Katerina; Degryse, Sandrine; Xu, Chengqi; Novero, Domenico; Ponzoni, Maurilio; Tiacci, Enrico; Falini, Brunangelo; Song, Joo; Khodos, Inna; De Stanchina, Elisa; Macari, Gabriele; Cafforio, Luciana; Gardini, Simone; Piva, Roberto; Medico, Enzo; Ng, Samuel Y; Moskowitz, Allison; Epstein, Zachary; Intlekofer, Andrew; Ahmed, Dogan; Chan, Wing C; Martin, Peter; Ruan, Jia; Bertoni, Francesco; Foà, Robin; Brody, Joshua D; Weinstock, David M; Osan, Jaspreet; Santambrogio, Laura; Elemento, Oliver; Betel, Doron; Tam, Wayne; Ruella, Marco; Cerchietti, Leandro; Rabadan, Raul; Horwitz, Steven; Inghirami, Giorgio
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study
2016-01-01 Ruella, Marco; Filippi, Andrea Riccardo; Bruna, Riccardo; Di Russo, Anna; Magni, Michele; Caracciolo, Daniele; Passera, Roberto; Matteucci, Paola; Di Nicola, Massimo; Corradini, Paolo; Parvis, Guido; Gini, Guido; Olivieri, Attilio; Ladetto, Marco; Ricardi, Umberto; Tarella, Corrado; Devizzi, Liliana
Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy.
2013-01-01 Marmotti A; Castoldi F; Rossi R; Marenco S; Risso A; Ruella M; Tron A; Borrè A; Blonna D; Tarella C.
CAR T-cell Resistance to Oncogenic Transformation
2024-01-01 Ruella, Marco; June, Carl H
CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia
2025-01-01 Beyar-Katz, Ofrat; Benjamini, Ohad; Delgado, Julio; Ruella, Marco; Ram, Ron; Grisariu, Sigal; Visentin, Andrea; Vandenberghe, Elisabeth; Gentile, Massimo; Avigdor, Abraham; Shimoni, Avichai; Shouval, Roni; Marcus, Ronit; Schuster, Stephen J; Ortiz-Maldonado, Valentin; Ghilardi, Guido; Paruzzo, Luca; Zuckerman, Tsila; Tadmor, Tamar; Fineman, Riva; Amit, Odelia; Martinez-Cibrian, Nuria; Gabrielli, Giulia; Avni, Batia; Minga, Eva; Shem-Tov, Noga; Scarfo, Lydia; Yerushalmi, Ronit; Nagler, Arnon; Leiba, Ronit; Danylesko, Ivetta; Stamatopoulos, Kostas; Chatzikonstantinou, Thomas; Ghia, Paolo; Herishanu, Yair
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
2024-01-01 Patel, Ruchi P; Ghilardi, Guido; Zhang, Yunlin; Chiang, Yi-Hao; Xie, Wei; Guruprasad, Puneeth; Kim, Ki Hyun; Chun, Inkook; Angelos, Mathew G; Pajarillo, Raymone; Hong, Seok Jae; Lee, Yong Gu; Shestova, Olga; Shaw, Carolyn; Cohen, Ivan; Gupta, Aasha; Vu, Trang; Qian, Dean; Yang, Steven; Nimmagadda, Aditya; Snook, Adam E; Siciliano, Nicholas; Rotolo, Antonia; Inamdar, Arati; Harris, Jaryse; Ugwuanyi, Ositadimma; Wang, Michael; Carturan, Alberto; Paruzzo, Luca; Chen, Linhui; Ballard, Hatcher J; Blanchard, Tatiana; Xu, Chong; Abdel-Mohsen, Mohamed; Gabunia, Khatuna; Wysocka, Maria; Linette, Gerald P; Carreno, Beatriz; Barrett, David M; Teachey, David T; Posey, Avery D; Powell, Daniel J; Sauter, C Tor; Pileri, Stefano; Pillai, Vinodh; Scholler, John; Rook, Alain H; Schuster, Stephen J; Barta, Stefan K; Porazzi, Patrizia; Ruella, Marco
Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status
2010-01-01 Ruella M; Rocci A; Ricca I; Carniti C; Bodoni CL; Ladetto M; Caracciolo D; Boccadoro M; Carlo-Stella C; Corradini P; Tarella C.
DLBCL Cells Emerge after CD19 CAR T Cells with Cross-Antigen Resistance and a Gene Signature Predictive of Clinical CAR T-cell Response
2025-01-01 Lüönd, Fabiana; Whalen, Jeanne; Song, Youngchul; Schriefer, Kalyn; Newcombe, Rick; Orlando, Elena J; Choi, Sarah M; Ruella, Marco; Fraietta, Joseph A; Schuster, Stephen J; Brogdon, Jennifer L; Niederst, Matthew J; Treanor, Louise M
EZH2 Inhibitors Enhance CART Cell Quality, Efficacy, In Vivo Homing, Tumor Cell Binding and Killing of Fully Syngeneic Primary B Cell Lymphomas, As Well As Reprogramming Lymphoma Cells to a Highly Immunogenic and T Cell Adherent Phenotype
2023-01-01 Isshiki, Y; Porazzi, P; Chen, X; Teater, M; Karagiannidis, I; Nam, HS; Melnick, AM; Ruella, M; Baguelin, W
Haploidentical cellular therapy in elderly patients with acute myeloid leukemia: description of its use in high risk patients.
2013-01-01 Cignetti A; Ruella M; Elia A; Tassi V; Redoglia V; Gottardi D; Tarella C.
How to train your T cell: Genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia
2015-01-01 Ruella, M.; Gill, S.
Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose
2013-01-01 130. Devizzi L; Guidetti A; Seregni E; Passera R; Maccauro M; Magni M; Testi A; Di Nicola M; Tarella C; Matteucci P; Viviani S; Ruella M; Carlo-Stella C; Chiesa C; Cox MC; Bombardieri E; Gianni AM.
Multiple courses of G-CSF in patients with decompensated cirrosi: consistent mobilization of immature cells ex pressing hepatocyte markers and exploratory clinical evaluation.
2013-01-01 Gaia S; Olivero A; Smedile A; Ruella M; Abate ML; Fadda M; Rolle E; Omdé P; Bondesan P; Passera r; Risso A; Aragno M; Marzano A; Ciancio A; Rizzetto M; Tarella C.
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia
2011-01-01 Guidetti A; Carlo-Stella C; Ruella M; Miceli R; Devizzi L; Locatelli SL; Giacomini A; Testi A; Buttiglieri S; Risso A; Mariani L; Di Nicola M; Passera R; Tarella C; Gianni AM
Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin's Lymphoma: Correlation with Long-Term Survival
2014-01-01 Tarella C; Gueli A; Delaini F; Rossi A; Barbui AM; Gritti G; Boschini C; Caracciolo D; Bruna R; Ruella M; Gottardi D; Passera R; Rambaldi A.
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma
2013-01-01 Ferrero, Simone; Monitillo, Luigia; Mantoan, Barbara; Barbero, Daniela; Genuardi, Elisa; Barbiero, Sara; Bernocco, Elisa; Caracciolo, Daniele; Ruella, Marco; Drandi, Daniela; Zanni, Manuela; Renna, Federica; Lobetti Bodoni, Chiara; Gueli, Angela; Passera, Roberto; Musto, Pellegrino; Boccadoro, Mario; Tarella, Corrado; Ladetto, Marco
The aging effect of chemotherapy on cultured human mesenchymal stem cells
2011-01-01 Buttiglieri S; Ruella M; Risso A; Spatola T; Silengo L; Avvedimento EV; Tarella C
Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
2012-01-01 Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities | 2025 | Fiore, Danilo; Cappelli, Luca Vincenzo; Zhaoqi, Liu; Kotlov, Nikita; Sorokina, Maria; Phillip, Jude; Zumbo, Paul; Yoffe, Liron; Ghione, Paola; Wang, Anqi; Han, Xueshuai; Taylor, Abigail; Chiu, William; Fragliasso, Valentina; Tabbo, Fabrizio; Zamponi, Nahuel; Di Siervi, Nicolás; Kayembe, Clarisse; Medico, Giovanni; Patel, Ruchi P; Gaudiano, Marcello; Machiorlatti, Rodolfo; Astone, Giuseppina; Cacciapuoti, Maria Teresa; Zanetti, Giorgia; Pignataro, Claudia; Eric, Ruiz Arvin; Patel, Sanjay; Zammarchi, Francesca; Zanettini, Claudio; Queiroz, Lucio; Nikitina, Anastasia; Kudryashova, Olga; Karelin, Anton; Nikitin, Daniil; Tychinin, Dmitry; Postovalova, Ekaterina; Bagaev, Alexander; Svekolkin, Viktor; Belova, Ekaterina; Tikhonova, Katerina; Degryse, Sandrine; Xu, Chengqi; Novero, Domenico; Ponzoni, Maurilio; Tiacci, Enrico; Falini, Brunangelo; Song, Joo; Khodos, Inna; De Stanchina, Elisa; Macari, Gabriele; Cafforio, Luciana; Gardini, Simone; Piva, Roberto; Medico, Enzo; Ng, Samuel Y; Moskowitz, Allison; Epstein, Zachary; Intlekofer, Andrew; Ahmed, Dogan; Chan, Wing C; Martin, Peter; Ruan, Jia; Bertoni, Francesco; Foà, Robin; Brody, Joshua D; Weinstock, David M; Osan, Jaspreet; Santambrogio, Laura; Elemento, Oliver; Betel, Doron; Tam, Wayne; Ruella, Marco; Cerchietti, Leandro; Rabadan, Raul; Horwitz, Steven; Inghirami, Giorgio | |
| Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study | 2016 | Ruella, Marco; Filippi, Andrea Riccardo; Bruna, Riccardo; Di Russo, Anna; Magni, Michele; Caracciolo, Daniele; Passera, Roberto; Matteucci, Paola; Di Nicola, Massimo; Corradini, Paolo; Parvis, Guido; Gini, Guido; Olivieri, Attilio; Ladetto, Marco; Ricardi, Umberto; Tarella, Corrado; Devizzi, Liliana | |
| Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy. | 2013 | Marmotti A; Castoldi F; Rossi R; Marenco S; Risso A; Ruella M; Tron A; Borrè A; Blonna D; Tarella C. | |
| CAR T-cell Resistance to Oncogenic Transformation | 2024 | Ruella, Marco; June, Carl H | |
| CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia | 2025 | Beyar-Katz, Ofrat; Benjamini, Ohad; Delgado, Julio; Ruella, Marco; Ram, Ron; Grisariu, Sigal; Visentin, Andrea; Vandenberghe, Elisabeth; Gentile, Massimo; Avigdor, Abraham; Shimoni, Avichai; Shouval, Roni; Marcus, Ronit; Schuster, Stephen J; Ortiz-Maldonado, Valentin; Ghilardi, Guido; Paruzzo, Luca; Zuckerman, Tsila; Tadmor, Tamar; Fineman, Riva; Amit, Odelia; Martinez-Cibrian, Nuria; Gabrielli, Giulia; Avni, Batia; Minga, Eva; Shem-Tov, Noga; Scarfo, Lydia; Yerushalmi, Ronit; Nagler, Arnon; Leiba, Ronit; Danylesko, Ivetta; Stamatopoulos, Kostas; Chatzikonstantinou, Thomas; Ghia, Paolo; Herishanu, Yair | |
| CD5 deletion enhances the antitumor activity of adoptive T cell therapies | 2024 | Patel, Ruchi P; Ghilardi, Guido; Zhang, Yunlin; Chiang, Yi-Hao; Xie, Wei; Guruprasad, Puneeth; Kim, Ki Hyun; Chun, Inkook; Angelos, Mathew G; Pajarillo, Raymone; Hong, Seok Jae; Lee, Yong Gu; Shestova, Olga; Shaw, Carolyn; Cohen, Ivan; Gupta, Aasha; Vu, Trang; Qian, Dean; Yang, Steven; Nimmagadda, Aditya; Snook, Adam E; Siciliano, Nicholas; Rotolo, Antonia; Inamdar, Arati; Harris, Jaryse; Ugwuanyi, Ositadimma; Wang, Michael; Carturan, Alberto; Paruzzo, Luca; Chen, Linhui; Ballard, Hatcher J; Blanchard, Tatiana; Xu, Chong; Abdel-Mohsen, Mohamed; Gabunia, Khatuna; Wysocka, Maria; Linette, Gerald P; Carreno, Beatriz; Barrett, David M; Teachey, David T; Posey, Avery D; Powell, Daniel J; Sauter, C Tor; Pileri, Stefano; Pillai, Vinodh; Scholler, John; Rook, Alain H; Schuster, Stephen J; Barta, Stefan K; Porazzi, Patrizia; Ruella, Marco | |
| Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status | 2010 | Ruella M; Rocci A; Ricca I; Carniti C; Bodoni CL; Ladetto M; Caracciolo D; Boccadoro M; Carlo-Stella C; Corradini P; Tarella C. | |
| DLBCL Cells Emerge after CD19 CAR T Cells with Cross-Antigen Resistance and a Gene Signature Predictive of Clinical CAR T-cell Response | 2025 | Lüönd, Fabiana; Whalen, Jeanne; Song, Youngchul; Schriefer, Kalyn; Newcombe, Rick; Orlando, Elena J; Choi, Sarah M; Ruella, Marco; Fraietta, Joseph A; Schuster, Stephen J; Brogdon, Jennifer L; Niederst, Matthew J; Treanor, Louise M | |
| EZH2 Inhibitors Enhance CART Cell Quality, Efficacy, In Vivo Homing, Tumor Cell Binding and Killing of Fully Syngeneic Primary B Cell Lymphomas, As Well As Reprogramming Lymphoma Cells to a Highly Immunogenic and T Cell Adherent Phenotype | 2023 | Isshiki, Y; Porazzi, P; Chen, X; Teater, M; Karagiannidis, I; Nam, HS; Melnick, AM; Ruella, M; Baguelin, W | |
| Haploidentical cellular therapy in elderly patients with acute myeloid leukemia: description of its use in high risk patients. | 2013 | Cignetti A; Ruella M; Elia A; Tassi V; Redoglia V; Gottardi D; Tarella C. | |
| How to train your T cell: Genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia | 2015 | Ruella, M.; Gill, S. | |
| Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose | 2013 | 130. Devizzi L; Guidetti A; Seregni E; Passera R; Maccauro M; Magni M; Testi A; Di Nicola M; Tarella C; Matteucci P; Viviani S; Ruella M; Carlo-Stella C; Chiesa C; Cox MC; Bombardieri E; Gianni AM. | |
| Multiple courses of G-CSF in patients with decompensated cirrosi: consistent mobilization of immature cells ex pressing hepatocyte markers and exploratory clinical evaluation. | 2013 | Gaia S; Olivero A; Smedile A; Ruella M; Abate ML; Fadda M; Rolle E; Omdé P; Bondesan P; Passera r; Risso A; Aragno M; Marzano A; Ciancio A; Rizzetto M; Tarella C. | |
| Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia | 2011 | Guidetti A; Carlo-Stella C; Ruella M; Miceli R; Devizzi L; Locatelli SL; Giacomini A; Testi A; Buttiglieri S; Risso A; Mariani L; Di Nicola M; Passera R; Tarella C; Gianni AM | |
| Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin's Lymphoma: Correlation with Long-Term Survival | 2014 | Tarella C; Gueli A; Delaini F; Rossi A; Barbui AM; Gritti G; Boschini C; Caracciolo D; Bruna R; Ruella M; Gottardi D; Passera R; Rambaldi A. | |
| Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma | 2013 | Ferrero, Simone; Monitillo, Luigia; Mantoan, Barbara; Barbero, Daniela; Genuardi, Elisa; Barbiero, Sara; Bernocco, Elisa; Caracciolo, Daniele; Ruella, Marco; Drandi, Daniela; Zanni, Manuela; Renna, Federica; Lobetti Bodoni, Chiara; Gueli, Angela; Passera, Roberto; Musto, Pellegrino; Boccadoro, Mario; Tarella, Corrado; Ladetto, Marco | |
| The aging effect of chemotherapy on cultured human mesenchymal stem cells | 2011 | Buttiglieri S; Ruella M; Risso A; Spatola T; Silengo L; Avvedimento EV; Tarella C | |
| Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report. | 2012 | Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C. |